Key Takeaways
Peptide therapy has been treating diabetes since insulin’s discovery in 1921 and now includes modern GLP-1s, like Ozempic.
Over 100 peptide drugs are FDA-approved, but many others are off-label or unapproved. Always consult a doctor first.
Future peptide research may help address diabetes-related complications like wound healing and depression.
Have you noticed more discussion around peptide therapy lately? Peptide therapy isn’t new. It began in the 1920s and has been prescribed to people for years to treat various conditions, including diabetes and obesity. Today, the medical community has been exploring peptide therapy for other uses, and influencers are selling peptides with big wellness claims.
This article cuts through the noise. We’ll discuss the current uses of peptide therapy for diabetes and the future directions that have yet to receive medical approval.
What Is Peptide Therapy?
Peptide therapy is an umbrella term for treatments that use short chains of amino acids, called peptides, to influence how the body functions.
These chains act as messengers, and they’re designed to deliver specific instructions on how targeted molecules and cells should behave. They control multiple aspects of our bodies, like our metabolism (how we use energy) and immune system (how we defend ourselves against illness). These functions include how we rid our cells of waste and how tissues heal. (1)
One peptide doesn’t influence all pathways, which means there are multiple drugs to target different body functions.
Can Peptide Therapy Help Diabetes?
Peptide therapy can help with diabetes — in fact, the first peptide therapy was insulin.
When insulin was discovered in 1921, it transformed how doctors treated diabetes. Before insulin, the first-line treatment was severe calorie restriction, and many people died. (2) Insulin saved lives and even helped scientists develop other life-changing medications, like biologics for cancer or autoimmune diseases. (Rehman)
Another peptide used to treat diabetes is Symlin (pramlintide), a synthetic version of the peptide amylin. It’s used alongside mealtime insulin for both type 1 and type 2 diabetes to help curb spikes in blood sugar. (6)
Today, the most discussed type of peptide therapy is glucagon-like peptide-1 (GLP-1) receptor agonists. GLP-1 medications were first developed to help manage blood sugar for people with type 2 diabetes. They’re also widely used for weight loss. (1) Common GLP-1s include:
Semaglutide (Ozempic, Wegovy)
Tirzepatide (Mounjaro, Zepbound)
Liraglutide (Saxenda)
Total Diabetes Supply now offers prescriptions for weight loss. Once you complete an online consultation, a licensed provider will review your profile and prescribe your treatment. Then, it’s shipped discreetly to your door. Join our Rx Program today.
Other Peptide Therapies
The U.S. Food and Drug Administration (FDA) has approved more than 100 peptide drugs targeting various functions of the body. (3) Some are relevant to those with diabetes.
For example, peptides exist to treat sexual health. Vyleesi (bremelanotide) is an FDA-approved peptide used to treat hypoactive sexual desire disorder in premenopausal women. (4) It’s also sometimes used off-label for sexual dysfunction in men, which is linked to diabetes. (5)
However, off-label use means doctors can prescribe the medication for a condition for which evidence indicates it is effective, but it’s not FDA-approved. Many peptide treatments available off-label or over-the-counter are not approved, so use peptides with caution — especially when treating issues related to diabetes, like hair loss or skin health problems, alongside your current medication regimen. Always consult with a doctor about starting or mixing any medications or supplements.
The Future of Peptide Therapy and Diabetes
Peptide therapy is at the forefront of modern research given its track record of medical breakthroughs, particularly in the diabetes community.
One direction researchers are exploring is orthopedics to treat muscle and bone conditions. Experts think peptides could be valuable in muscle and cartilage repair for recovering athletes, but they could also be useful in older adults with thinning muscle or joint inflammation (arthritis). (1) Diabetes and arthritis are highly connected — those with arthritis have a 61 percent higher risk of developing diabetes than those without it. (7)
Neurologic conditions and psychological health are another direction. Experts believe the brain, spinal cord, and other nerves in the body could recover better with targeted peptide therapy. (1) We often associate diabetes with diabetic neuropathy, or damaged nerves due to uncontrolled blood sugar. But we don’t always consider the mental toll of the disease. People with diabetes are two to three times more likely to develop depression compared to those without, but only about half get treatment. Future peptide therapies could make psychological treatment more effective or accessible. (8)
Researchers are also looking into peptide therapy for wound healing. Targeted peptides may influence how cells form new tissue. Most experts are studying how peptides can help people heal faster after surgeries to repair muscle or other soft tissues. But this opens up a big opportunity for future studies to explore how peptides can shorten healing times in people with diabetes — foot ulcers and tissue regeneration can be major concerns among those with diabetes, and peptides may one day help. (1) In the meantime, you can take care of your feet by keeping them moisturized and performing daily foot checks to make sure they’re healthy.
EASE-Z Diabetics Dry Skin Therapy Foot Cream
$ 16.96
$ 20.59
EASE-Z Diabeticsโ Dry Skin Foot Cream is a diabetic's solution forย dry, cracked itchy feet. Contains active ingredient ZINC Acetate adding a protective barrier and promotes the healing of minor sores and wounds. Can be used daily to reveal powerful results… read more
Bottom Line
Peptide therapy has come a long way since insulin revolutionized diabetes treatment more than 100 years ago. Its potential is only growing. Current and future research has the potential to reshape how we approach diabetes care.
However, with so many treatments available without FDA approval, it’s important to work closely with your doctor before adding any peptide therapies to your treatment plan.
References
Rahman, O. F., Lee, S. J., & Seeds, W. A. (2026). Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions. JAAOS Global Research & Reviews, 10(1), e25.00236. https://doi.org/10.5435/JAAOSGlobal-D-25-00236
American Diabetes Association. (2019, July 1). The history of a wonderful thing we call insulin. https://diabetes.org/blog/history-wonderful-thing-we-call-insulin
Willson, A. (2026, March 3). The top 10 things to understand about peptides. American Society of Plastic Surgeons. https://www.plasticsurgery.org/news/articles/the-top-10-things-to-understand-about-peptides
Stewart, J. (2025, January 18). Vyleesi FDA approval history. Drugs.com. https://www.drugs.com/history/vyleesi.html
Goldstein, S., & Goldstein, I. (2024). (235) Use of Bremelanotide (Vyleesi) in Men with Sexual Dysfunctions. The Journal of Sexual Medicine, 21(Supplement_1). https://doi.org/10.1093/jsxmed/qdae001.225
Mayo Clinic. (2026, June 1). Pramlintide (subcutaneous route). https://www.mayoclinic.org/drugs-supplements/pramlintide-subcutaneous-route/description/drg-20065595
Watson, S. (2020, April 15). The link between arthritis and diabetes. Arthritis Foundation. https://www.arthritis.org/health-wellness/about-arthritis/related-conditions/other-diseases/the-link-between-arthritis-and-diabetes
Diabetes and mental health. (2024, May 15). Diabetes. https://www.cdc.gov/diabetes/living-with/mental-health.html
Cleveland Clinic. (2023, July 3). GLP-1 agonists: What they are, how they work & side effects. https://my.clevelandclinic.org/health/treatments/13901-glp-1-agonists